Company

Built by scientists, for scientists.

Why we exist

Drug development is too slow to trust to chance, and too important to leave to spreadsheets.

We're scientists and builders who got tired of watching good molecules die in undifferentiated process instead of hard science. DVLP pairs a governed AI layer with the discipline regulated development demands, so a small team can move like a much larger one, without asking anyone to trust a black box.

Leadership

Mehmood Khan, MD

Chairman of the Board

Jason Paragas

CEO

Patrick Perry

Co-founder / CFO / GM

Flo Mazzoldi

Co-founder / CTO

Harper Lee Kaye

Co-founder / GM, Pharma Sciences

Scientific Advisory Board

Robert Franco

Senior Fellow, Tufts CSDD; former Lead Partner, PwC Pharmaceutical R&D

Steve Projan

Former SVP R&D, MedImmune; Global Head of Infectious Diseases, Novartis Institute for BioMedical Research

John Baldoni

Former SVP Platform Technology & Science, GSK R&D; launched GSK's first AI-driven drug discovery unit

Work with us.

Bring a program, or bring your expertise. We're always looking for scientists and operators who want to build this with us.